Stay updated on BHV-7000 in Adults With Refractory Focal Onset Epilepsy Clinical Trial
Sign up to get notified when there's something new on the BHV-7000 in Adults With Refractory Focal Onset Epilepsy Clinical Trial page.

Latest updates to the BHV-7000 in Adults With Refractory Focal Onset Epilepsy Clinical Trial page
- Check2 days agoChange DetectedA new site revision tag 'Revision: v3.3.0' is displayed, and the older 'Revision: v3.2.0' tag along with the government-funding operating-status notice has been removed.SummaryDifference0.4%

- Check16 days agoNo Change Detected
- Check23 days agoChange Detected- No substantive content changes detected; the study details, design, eligibility criteria, and outcomes remain the same between screenshots. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check45 days agoChange DetectedThe page has been updated to reflect a later recruitment timeline and expanded site locations for the study, changing from 124 to 125 sites and updating the recruitment status to Recruiting with newer date references. Overall status now shows an active, multi-site study with 2025-10 timelines and an estimated last update, replacing earlier 2025-05/08/09 references.SummaryDifference1%

- Check52 days agoChange DetectedPage version updated from v3.0.2 to v3.2.0, accompanied by a large insertion of new contact emails and phone numbers for various individuals/organizations.SummaryDifference0.1%

- Check60 days agoChange DetectedRemoved several core sections on drug safety and quality (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs).SummaryDifference0.2%

- Check67 days agoChange Detected- Updated the page revision from v3.0.1 to v3.0.2. - Removed the previous revision tag and the 'Back to Top' anchor.SummaryDifference0.1%

Stay in the know with updates to BHV-7000 in Adults With Refractory Focal Onset Epilepsy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BHV-7000 in Adults With Refractory Focal Onset Epilepsy Clinical Trial page.